SOPH (Sophia Genetics) Goodwill-to-Asset: 0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SOPH Sophia Genetics SA SOPH
66 GF Score
Price $7.87
GF Value $5.14
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sophia Genetics Goodwill-to-Asset?

Sophia Genetics SOPH +3.42% 66 Goodwill-to-Asset is 0.00 as of Jun. 2026. GuruFocus rates SOPH with a GF Score™ of 66/100 and a GF Value™ of $5.14 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. Sophia Genetics's Goodwill for the quarter that ended in Jun. 2026 was $0.00 Mil. Sophia Genetics's Total Assets for the quarter that ended in Jun. 2026 was $198.36 Mil. Therefore, Sophia Genetics's Goodwill to Asset Ratio for the quarter that ended in Jun. 2026 was 0.00.


Sophia Genetics  (NAS:SOPH) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


Sophia Genetics Goodwill-to-Asset Related Terms


Sophia Genetics Goodwill-to-Asset Historical Data

* Premium members only.

The historical data trend for Sophia Genetics's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sophia Genetics Goodwill-to-Asset Chart

Sophia Genetics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Goodwill-to-Asset
Get a 7-Day Free Trial 0.03 0.03 0.04 0.05 0.06

Sophia Genetics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Goodwill-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.06 0.00 0.00

SOPH vs CTEV, PHR, WEAV: Goodwill-to-Asset Comparison

For the Health Information Services subindustry, Sophia Genetics's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sophia Genetics Goodwill-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where Sophia Genetics's Goodwill-to-Asset falls into.


SOPH
66GF Score
Sophia Genetics SA SOPH
Goodwill-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sophia Genetics Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Sophia Genetics's Goodwill to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Goodwill to Asset (A: Dec. 2025 )=Goodwill/Total Assets
=9.556/163.031
=0.06

Sophia Genetics's Goodwill to Asset Ratio for the quarter that ended in Jun. 2026 is calculated as

Goodwill to Asset (Q: Jun. 2026 )=Goodwill/Total Assets
=0/198.359
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Goodwill-to-Asset →
What does a Goodwill-to-Asset of 0.00 mean?
Sophia Genetics (SOPH) has a Goodwill-to-Asset of 0.00 as of Jun. 2026. Goodwill-to-Asset Ratio is the total goodwill from acquisitions divided by total assets. View historical data on Sophia Genetics and its competitors.
Is Sophia Genetics' Goodwill-to-Asset too high?
Sophia Genetics' current Goodwill-to-Asset is 0.00. Overall, Sophia Genetics has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sophia Genetics' Goodwill-to-Asset compare to CTEV and PHR?
Sophia Genetics' Goodwill-to-Asset of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Goodwill-to-Asset for a Healthcare Providers & Services company?
A good Goodwill-to-Asset depends on the Healthcare Providers & Services industry context. However, Goodwill-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Goodwill-to-Asset mean?
A high Goodwill-to-Asset can signal that a stock is expensive relative to its fundamentals. Goodwill-to-Asset Ratio is the total goodwill from acquisitions divided by total assets. View historical data on Sophia Genetics and its competitors. Sophia Genetics's current Goodwill-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sophia Genetics stock overvalued right now?
Based on GuruFocus' analysis, Sophia Genetics (SOPH) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.14, compared to a current price of $7.87 — trading 53.1% above its estimated fair value. The current Goodwill-to-Asset is 0.00. Sophia Genetics' overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Goodwill-to-Asset calculated?
Goodwill-to-Asset is calculated from a company's financial statements. For Sophia Genetics (SOPH), the current Goodwill-to-Asset is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sophia Genetics (SOPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of $7.87 is trading 53.1% above its estimated GF Value™ of $5.14. GuruFocus considers Sophia Genetics to be Significantly Overvalued.

Key valuation signals for SOPH:

  • Goodwill-to-Asset: 0.00
  • GF Value™: $5.14 vs. price of $7.87 (53.1% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the SOPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sophia Genetics Business Description

Other Exchanges 90B:Germany
Address La Piece 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
66GF Score

Get the complete analysis for SOPH

Goodwill-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.87
Price
$5.14
GF Value